Loading...

GPCR STRUCTURE THERAPEUTICS INC Product Launches 8-K Filing

STRC

GPCR

STRUCTURE THERAPEUTICS INC

(GPCR)

2024 8-K

Show Summary

Show Summary

Financial Statements

Financial Results

Q3 Financial Results

Management Changes

Director Appointment

Earnings Reports

Annual General Meeting

Press Release and Conferenc...

Earnings Reports

Earnings Reports

Collaboration Agreement wit...

Private Placement

Earnings Report

Appointment of Director and...

Dismissal of Independent Re...

Earnings Reports

Earnings Reports

Amended and Restated Memora...

External Links:

Structure Therapeutics Inc. announced the selection of its lead oral small molecule amylin receptor agonist, ACCG-2671, for treating obesity on December 17, 2024.

AI Assistant

STRUCTURE THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.